AN ACT TO AMEND SECTION 73-21-97, MISSISSIPPI CODE OF 1972, TO AUTHORIZE THE STATE BOARD OF PHARMACY TO ESTABLISH BY RULE AN ALTERNATIVE TO DISCIPLINE PROGRAM FOR LICENSEES WHO HAVE AN IMPAIRMENT AS A RESULT OF SUBSTANCE ABUSE OR A MENTAL HEALTH CONDITION; TO PROVIDE THAT PARTICIPATION IN THE PROGRAM IS VOLUNTARY WITH THE LICENSEE, AND THE LICENSEE MUST ENTER THE PROGRAM BEFORE THE BOARD HOLDS A DISCIPLINARY ACTION HEARING REGARDING THE LICENSEE; TO PROVIDE THAT THE LICENSEE MAY BE REQUIRED TO CONTRIBUTE TO THE COST OF PARTICIPATION IN THE PROGRAM, INCLUDING THE COST OF ANY CARE, COUNSELING, TREATMENT AND/OR EDUCATION RECEIVED BY THE LICENSEE; AND FOR RELATED PURPOSES.
Impact
The enactment of HB 1134 would likely lead to changes in how the State Board of Pharmacy conducts its disciplinary hearings. By allowing impaired licensees to enter a voluntary alternative to discipline program before being subjected to disciplinary actions, the bill aims to facilitate rehabilitation and recovery processes. Additionally, it emphasizes that participation in this program will be confidential, shielding the personal details of those seeking assistance from public disclosure. This may foster a culture in the pharmacy profession where individuals feel safer disclosing their struggles without fear of immediate repercussions.
Summary
House Bill 1134 introduces significant amendments to Section 73-21-97 of the Mississippi Code of 1972, aimed at establishing an alternative to disciplinary actions for pharmacy licensees with impairments derived from substance abuse or mental health conditions. The bill empowers the State Board of Pharmacy to create a program that provides a pathway for impaired licensees to receive support rather than face outright punitive measures. Such initiatives reflect a growing recognition of the importance of addressing the root causes of professional misconduct related to addiction and mental health issues.
Contention
A potential area of contention surrounding HB 1134 lies in its implementation and the perception of accountability within the pharmacy profession. Proponents of the bill argue that it is a progressive step towards improving public health by encouraging licensees to seek help rather than risking their careers through disciplinary actions. However, critics could express concerns regarding the adequacy of such programs in ensuring patient safety, particularly if licensees who are not fully recovered are allowed to continue practicing under certain conditions. The balance between support and accountability will be pivotal in discussions as the bill moves through the legislative process.